Therapeutic strategy based on severity and MDR risk factors in all cause pneumonia-A 3 year prospective cohort study

Not Applicable

Completed

• Conditions: Patients with Community-Acquired, Health Care-Associated, Hospital-Acquired or ventilator associated pneumonia

• Registration Number: JPRN-jRCT1090220146
• Lead Sponsor: ational Hospital Organization Mie National Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-11-01
• Study Completion: 2017-09-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1200

Inclusion Criteria

Patients with Community-Acquired, Health Care-Associated, Hospital-Acquired or ventilator associated pneumonia

Exclusion Criteria

Patients with pulmonary tuberculosis and an infiltrate other than pneumonia, i.e., acute congestive heart failure, pulmonary infarction or interstitial pneumonia.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the efficacy of the algorithm for guiding the initial empiric therapy for all cause pneumonia.

Secondary Outcome Measures

Name	Time	Method
To compare the baseline characteristics, presence of MDR risk factors, etiology, antibiotic regimens and outcomes for: 1) each pneumonia group (CAP, HCAP, HAP and VAP patients); 2) patients with 0-1 MDR risks vs. patients with >=2 MDR risks in all cause pneumonia; and 3) non-severe pneumonia vs. severe pneumonia in all cause pneumonia.